ENTERA BIO LTD (ENTX:NASDAQ)
$1.13 -0.02 (-1.7391%)
Analysed ENTERA BIO LTD (ENTX:NASDAQ) News Sources
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
02-04-2026
yahoo.com
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
27-03-2026
yahoo.com
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
04-03-2026
yahoo.com
Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
27-02-2026
yahoo.com
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference
26-02-2026
yahoo.com
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation
18-02-2026
yahoo.com
Entera Bio Announces Open Market Purchases of Company Stock by Board Members
11-02-2026
yahoo.com
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones
09-02-2026
yahoo.com
Opko Health (OPK) Expands Entera Partnership for Drug Co-Development
06-02-2026
yahoo.com
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
04-02-2026
yahoo.com
What is the current price of ENTERA BIO LTD (ENTX:NASDAQ)?
The current price of ENTERA BIO LTD (ENTX:NASDAQ) is $1.13.
ENTERA BIO LTD (ENTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is $-0.02.
ENTERA BIO LTD (ENTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is -1.7391%.
What is the most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ)?
The most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ENTERA BIO LTD (ENTX:NASDAQ)?
The most recent sentiment for ENTERA BIO LTD (ENTX:NASDAQ) is .
SEC-8K** Filing Available For ENTERA BIO LTD (ENTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.